How analgesia-sedation alters monocyte mCD14 and HLA-DR levels in patients undergoing cerebral angiography?

Sibel Akyol1, Ercan Tureci, Taner Tanriverdi

  • 1Istanbul University, Cerrahpasa Medical Faculty, Department of Physiology, Istanbul, Turkey.

Turkish Neurosurgery
|December 7, 2013
PubMed

Insights

Analgesia-sedation significantly impacts immune cells like T lymphocytes during cerebral angiography. This suggests a need for tailored anesthetic approaches based on patient immunology to mitigate immune suppression.

Area of Science:

  • Immunology
  • Neuroscience
  • Anesthesiology

Background:

  • Cerebral angiography procedures carry risks that may be influenced by patient immune status.
  • Understanding the immunomodulatory effects of analgesia-sedation is crucial for patient management.

Purpose of the Study:

  • To investigate the impact of analgesia-sedation on Human Leukocyte Antigen - antigen D Related (HLA-DR) and cytokine levels (IL-10, IL-6) in patients undergoing cerebral angiography.
  • To assess changes in immune cell populations following cerebral angiography with and without analgesia-sedation.

Main Methods:

  • A cohort of 41 male patients undergoing cerebral angiography was studied.
  • Patients were divided into two groups: one receiving analgesia-sedation (Group II, n=34) and a control group (Group I, n=7).
  • Venous blood samples were collected pre- and post-procedure for immunological analysis.

Main Results:

  • Analgesia-sedation led to a significant increase in CD4+ and CD19+ T lymphocytes (p < 0.001).
  • The control group (no analgesia-sedation) exhibited a significant increase in CD40, CD154, and MHC-II levels (p < 0.001) post-procedure.
  • Fentanyl and midazolam's effects on immune response appear linked to monocyte and mHLA-DR expression.

Conclusions:

  • Analgesia-sedation, specifically fentanyl and midazolam, influences immune responses, potentially via monocyte and mHLA-DR expression.
  • Future anesthetic strategies should consider individual patient immunological status.
  • Development of anesthetic agents that minimize immune suppression is warranted for patients undergoing cerebral angiography.
Abstract

Related Concept Videos

Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
2.6K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
2.0K